Lisa Bloudek

2.3k total citations
54 papers, 1.6k citations indexed

About

Lisa Bloudek is a scholar working on Psychiatry and Mental health, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Lisa Bloudek has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 13 papers in Surgery and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Lisa Bloudek's work include Migraine and Headache Studies (15 papers), Trigeminal Neuralgia and Treatments (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Lisa Bloudek is often cited by papers focused on Migraine and Headache Studies (15 papers), Trigeminal Neuralgia and Treatments (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Lisa Bloudek collaborates with scholars based in United States, United Kingdom and Ireland. Lisa Bloudek's co-authors include Sepideh F. Varon, Zsolt Hepp, Richard B. Lipton, Sean D. Sullivan, Andrew Blumenfeld, Dawn C. Buse, Gregory A. Maglinte, Teresa K. Wilcox, Eldon Spackman and Michael Blankenburg and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Lisa Bloudek

49 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Bloudek United States 13 1.3k 806 474 178 143 54 1.6k
Sandhya Sapra United States 15 1.1k 0.9× 715 0.9× 401 0.8× 117 0.7× 82 0.6× 56 1.4k
Zsolt Hepp United States 13 883 0.7× 589 0.7× 266 0.6× 234 1.3× 85 0.6× 54 1.3k
Joe Hirman United States 18 1.5k 1.1× 1.1k 1.3× 675 1.4× 87 0.5× 131 0.9× 53 1.8k
Jeff Smith United States 25 1.2k 0.9× 873 1.1× 758 1.6× 446 2.5× 98 0.7× 52 2.4k
Timothy R. Smith United States 19 842 0.6× 460 0.6× 453 1.0× 165 0.9× 212 1.5× 44 1.7k
Shashidhar Kori United States 19 654 0.5× 402 0.5× 316 0.7× 246 1.4× 130 0.9× 46 1.1k
Mark J. Stillman United States 21 506 0.4× 246 0.3× 263 0.6× 95 0.5× 161 1.1× 52 1.1k
Pooja Desai United States 17 521 0.4× 275 0.3× 164 0.3× 65 0.4× 60 0.4× 45 823
Diana Degan Italy 12 491 0.4× 186 0.2× 125 0.3× 83 0.5× 133 0.9× 18 1.1k
Anders Ottosson Sweden 15 279 0.2× 162 0.2× 315 0.7× 98 0.6× 50 0.3× 41 906

Countries citing papers authored by Lisa Bloudek

Since Specialization
Citations

This map shows the geographic impact of Lisa Bloudek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Bloudek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Bloudek more than expected).

Fields of papers citing papers by Lisa Bloudek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Bloudek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Bloudek. The network helps show where Lisa Bloudek may publish in the future.

Co-authorship network of co-authors of Lisa Bloudek

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Bloudek. A scholar is included among the top collaborators of Lisa Bloudek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Bloudek. Lisa Bloudek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bloudek, Lisa, et al.. (2025). Public Health Impact of the MVA-BN Vaccine During the 2022 Mpox Outbreak: A Systematic Review. Infectious Disease Reports. 17(5). 124–124.
2.
Campbell, David J., Lisa Bloudek, Josh J. Carlson, et al.. (2024). Development of stakeholder-informed recommendations for inclusion of family spillover effects in health technology assessment. Journal of Managed Care & Specialty Pharmacy. 30(9). 1013–1024. 2 indexed citations
3.
Bloudek, Lisa, et al.. (2024). Systematic literature review and network meta-analysis of first-line therapies for locally advanced/metastatic urothelial carcinoma.. Journal of Clinical Oncology. 42(16_suppl). e16547–e16547.
4.
McIntyre, Roger S., et al.. (2023). Total healthcare cost savings through improved bipolar I disorder identification using the Rapid Mood Screener in patients diagnosed with major depressive disorder. Current Medical Research and Opinion. 39(4). 605–611. 1 indexed citations
5.
Singh, Harshabad, Lisa Bloudek, Ling‐I Hsu, et al.. (2023). Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer. JNCI Cancer Spectrum. 8(1). 9 indexed citations
6.
Bloudek, Lisa, Phoebe Wright, Caroline McKay, et al.. (2023). Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC). Current Oncology. 30(4). 3637–3647. 8 indexed citations
7.
Yeung, Kai, et al.. (2022). P1 Estimating US National Prescription Drug Savings from Applying Value-Based Price Caps. Value in Health. 25(7). S287–S287. 1 indexed citations
8.
Musa, Fernanda, Elizabeth Brouwer, Naomi Schwartz, et al.. (2022). Trends in treatment patterns and costs of care among patients with advanced stage cervical cancer. Gynecologic Oncology. 164(3). 645–650. 12 indexed citations
9.
Wirtz, Heidi S., et al.. (2021). PCN118 Estimated Prevalence of Treated Locally Advanced or Metastatic Urothelial Carcinoma in Canada Using Simulation Modeling. Value in Health. 24. S41–S41. 1 indexed citations
10.
11.
12.
Rajagopalan, Krithika, Lisa Bloudek, Jessica Marvel, Carole Dembek, & Abhishek Kavati. (2018). Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US. International Journal of COPD. Volume 13. 3867–3877. 8 indexed citations
13.
Bloudek, Lisa, Anuja Roy, Jonathan Kish, et al.. (2016). Estimating the Economic Impact of Adding Panobinostat to a U.S. Formulary for Relapsed and/or Refractory Multiple Myeloma: A Budget Impact and Cost-Benefit Model. Journal of Managed Care & Specialty Pharmacy. 22(8). 991–1002. 7 indexed citations
14.
Messali, Andrew, et al.. (2014). Health Care Resource Utilization Following Initiation of a Triptan: A Retrospective Claims Analysis. Journal of Managed Care Pharmacy. 20(4). 368–375. 7 indexed citations
15.
Bloudek, Lisa, et al.. (2013). Cost-effectiveness of onabotulinumtoxinA for prophylaxis of headaches in adults with chronic migraine in Canada. Value in Health. 16(3). A105–A105. 2 indexed citations
16.
Bloudek, Lisa, Michael Stokes, Dawn C. Buse, et al.. (2012). Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). The Journal of Headache and Pain. 13(5). 361–378. 242 indexed citations
17.
Bloudek, Lisa, et al.. (2012). PND11 Cost of Cervical Dystonia in the United States. Value in Health. 15(4). A142–A143. 3 indexed citations
18.
Rendas‐Baum, Regina, Lisa Bloudek, Gregory A. Maglinte, & Sepideh F. Varon. (2012). The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients. Quality of Life Research. 22(5). 1123–1133. 81 indexed citations
19.
Bloudek, Lisa, et al.. (2011). PND32 HEALTH RESOURCE UTILIZATION AND COSTS FOR MIGRANEURS IN SCOTLAND. Value in Health. 14(3). A207–A208. 2 indexed citations
20.
Bloudek, Lisa, et al.. (2011). PND31 HEADACHE DAY HEALTH STATES AND TRANSITION PROBABILITIES FOR PATIENTS WITH CHRONIC MIGRAINE WITH AND WITHOUT HEADACHE PROPHYLAXIS. Value in Health. 14(3). A207–A207. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandhya Sapra Breakdown of academic impact, for papers by Zsolt Hepp Breakdown of academic impact, for papers by Joe Hirman Breakdown of academic impact, for papers by Jeff Smith Breakdown of academic impact, for papers by Timothy R. Smith Breakdown of academic impact, for papers by Shashidhar Kori Breakdown of academic impact, for papers by Mark J. Stillman Breakdown of academic impact, for papers by Pooja Desai Breakdown of academic impact, for papers by Diana Degan Breakdown of academic impact, for papers by Anders Ottosson
Rankless by CCL
2026